JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive: To the best of our knowledge, this is the first case reporting primary polycythemia associated with JAK2 V617F mutation negativity, but with the presence of the BCR-ABL1 fusion gene, pathognomonic of a CML diagnosis.